Trial
NCT00670410
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Neuroblastoma
Intervention
Related donor transplant
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-24